Fesoterodine fumarate

Details

Files

Generic Name:

Fesoterodine fumarate

Project Status:

Complete

Therapeutic Area:

Overactive bladder

Manufacturer:

Pfizer Canada Inc.

Call for patient/clinician input open:

April 27, 2012

Brand Name:

Toviaz

Project Line:

Reimbursement Review

Project Number:

SR0277-000

Call for patient/clinician input closed:

May 18, 2012

NOC Status at Filing:

Post NOC

Submission Type:

Initial

Indications:

Bladder, overactive

Recommendation Type:

List in a similar manner

Final Recommendation:

October 18, 2012

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : April 27, 2012